Free Trial

Adverum Biotechnologies (ADVM) SEC Filings & 10K Form

Adverum Biotechnologies logo
$6.04 +0.29 (+5.04%)
(As of 11/22/2024 ET)

Recent Adverum Biotechnologies SEC Filings

DateFilerForm TypeView
11/14/2024
5:40 PM
Adverum Biotechnologies (Subject)
Logos Global Management LP (Filed by)
Form SC 13G/A
11/14/2024
5:57 PM
Adverum Biotechnologies (Subject)
Vivo Opportunity Fund Holdings, L.P. (Filed by)
Form SC 13G/A
11/06/2024
4:49 PM
Adverum Biotechnologies (Subject)
MORGAN STANLEY (Filed by)
Form SC 13G/A
11/04/2024
3:42 PM
Adverum Biotechnologies (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/04/2024
3:44 PM
Adverum Biotechnologies (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
10/31/2024
11:41 AM
Adverum Biotechnologies (Subject)
FRANKLIN RESOURCES INC (Filed by)
Form SCHEDULE 13G
10/30/2024
8:34 PM
Adverum Biotechnologies (Subject)
Stern Augustus (Filed by)
Form SC 13G
10/23/2024
12:34 PM
Adverum Biotechnologies (Subject)
Principia Wealth Advisory, LLC (Filed by)
Form SC 13G
10/22/2024
5:06 PM
Adverum Biotechnologies (Subject)
BlackRock, Inc. (Filed by)
Form SC 13G
08/12/2024
3:08 PM
Adverum Biotechnologies (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/12/2024
3:10 PM
Adverum Biotechnologies (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
07/22/2024
3:24 PM
Adverum Biotechnologies (Subject)
BML Investment Partners, L.P. (Filed by)
Form SC 13G/A
07/18/2024
8:16 PM
Adverum Biotechnologies (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/18/2024
8:16 PM
Adverum Biotechnologies (Issuer)
Leonard Braden Michael (Reporting)
Leonard Braden Michael (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/18/2024
8:16 PM
Adverum Biotechnologies (Issuer)
Leonard Braden Michael (Reporting)
Leonard Braden Michael (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
07/17/2024
3:38 PM
Adverum Biotechnologies (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/20/2024
3:47 PM
Adverum Biotechnologies (Issuer)
Svoronos Dawn (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/20/2024
3:48 PM
Adverum Biotechnologies (Issuer)
Lupher, Jr. Mark L. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/20/2024
3:48 PM
Adverum Biotechnologies (Issuer)
Hong Soo (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/20/2024
3:49 PM
Adverum Biotechnologies (Issuer)
Nicholson, C. David (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/20/2024
3:50 PM
Adverum Biotechnologies (Issuer)
Ozden Rabia Gurses (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/20/2024
3:42 PM
Adverum Biotechnologies (Issuer)
Kiss Szilard (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
06/20/2024
3:43 PM
Adverum Biotechnologies (Issuer)
Kiss Szilard (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/20/2024
3:43 PM
Adverum Biotechnologies (Issuer)
Machado Patrick (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/20/2024
3:44 PM
Adverum Biotechnologies (Issuer)
Scopa James Paul (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/20/2024
3:45 PM
Adverum Biotechnologies (Issuer)
Whitcup Scott M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/20/2024
3:46 PM
Adverum Biotechnologies (Issuer)
Tuckson Reed Vaughn (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/09/2024
3:10 PM
Adverum Biotechnologies (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/31/2024
11:15 PM
Adverum Biotechnologies (Filer)
Form EFFECT
03/26/2024
11:15 PM
Adverum Biotechnologies (Filer)
Form EFFECT
03/21/2024
4:24 PM
Adverum Biotechnologies (Filer)
Form S-3
Registration statement under Securities Act of 1933  
03/20/2024
4:04 PM
Adverum Biotechnologies (Filer)
Form 424B3
03/20/2024
3:13 PM
Adverum Biotechnologies (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/12/2024
6:05 PM
Adverum Biotechnologies (Issuer)
Fischer Laurent (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/12/2024
6:06 PM
Adverum Biotechnologies (Issuer)
Soparkar Peter (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/12/2024
6:07 PM
Adverum Biotechnologies (Issuer)
Seyedkazemi Setareh (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/04/2024
3:40 PM
Adverum Biotechnologies (Filer)
Form S-3
Registration statement under Securities Act of 1933  
02/22/2024
2:47 PM
Adverum Biotechnologies (Subject)
Adverum Biotechnologies (Subject)
Logos Global Management LP (Filed by)
Logos Global Management LP (Filed by)
Form SC 13G
02/21/2024
2:39 PM
Adverum Biotechnologies (Filer)
Form D
Notice of Exempt Offering of Securities 
02/15/2024
3:17 PM
Adverum Biotechnologies (Subject)
TCG Crossover GP II, LLC (Filed by)
Form SC 13G
02/14/2024
7:26 PM
Adverum Biotechnologies (Subject)
Venrock Healthcare Capital Partners III, L.P. (Filed by)
Form SC 13G/A
I hate to say I told you so (Ad)

Last month, I openly declared that a Trump Presidency was going to kick off Tesla’s New Bullish Cycle Folks who listened and bought in when I said to are currently crushing it. As a matter of fact, all the trades we’ve opened ever since I made that public declaration have ALL been winners. And it’s simply because this Tesla indicator just flipped green on the stock…

02/13/2024
6:34 PM
Adverum Biotechnologies (Subject)
BANK OF AMERICA CORP /DE/ (Filed by)
Form SC 13G/A
02/12/2024
9:13 AM
Adverum Biotechnologies (Subject)
MORGAN STANLEY (Filed by)
Form SC 13G/A
02/09/2024
4:50 PM
Adverum Biotechnologies (Issuer)
Lupher, Jr. Mark L. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/09/2024
4:51 PM
Adverum Biotechnologies (Issuer)
Scopa James Paul (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/09/2024
7:35 AM
Adverum Biotechnologies (Subject)
FMR LLC (Filed by)
Form SC 13G/A
02/08/2024
7:45 AM
Adverum Biotechnologies (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/07/2024
10:36 AM
Adverum Biotechnologies (Subject)
BML Investment Partners, L.P. (Filed by)
Form SC 13G/A
02/06/2024
3:47 PM
Adverum Biotechnologies (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:ADVM) was last updated on 11/23/2024 by MarketBeat.com Staff
From Our Partners